Related Experiment Video
Updated: May 23, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
[Pharmacokinetics and tissue distribution of Schisandra chinensis extract in mice]
Jiao Guan1, He-Yun Zhu, Xiu-Rong Zhang
1College of Pharmacy, Jilin Medical College, Jilin 132013, China. rainbowguanjiao@sina.com
Objective:
To investigate the pharmacokinetics and tissue distribution of Schisandra chinensis in mice.
Methods:
Schisandrin in mice plasma and tissues including heart, liver, spleen, lung and kidney was quantitatively determined by HPLC.
Results:
The concentration-time curve of Schisandra chinensis extract was described by a single compartment model, Cmax was (2.17 +/- 0.27) mg/ mL, t(max) was (1.00 +/- 0.32) h, AUC0-->infinity, was (4.07 +/- 0.62) mg x h/mL. The sequence of distribution of schisandrin in mice body was as follows: liver > plasma > kidney > lung > heart > spleen.
Conclusion:
The distribution of extract in the body is abroad. Liver has relative high concentration of schisandrin, which is beneficial to the treatment of hepatic disease.
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Measurement of Bioavailability: Pharmacokinetic Methods
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution